BSX vs GEHC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BSX · Boston Scientific$42.75 ▼ 4.23%
GEHC · GE HealthCare Technologies$82.38 ▼ 1.64%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BSX -57.6%
- GEHC +12.3%
Head to head
| Metric | BSX | GEHC |
|---|---|---|
| Price | $42.75 | $82.38 |
| Change today | ▼ 4.23% | ▼ 1.64% |
| Market cap | $61.96B | $37.25B |
| Return, 3 months | -15.3% | +12.9% |
| Return, year to date | -55.2% | +0.6% |
| Return, 1 year | -57.3% | +12.9% |
| P/E (TTM) | 18.0 | 17.4 |
| P/B | 2.4 | 3.2 |
| P/E percentile vs own 5y | 1st | 43rd |
| Dividend yield | – | 0.17% |
| Revenue growth (YoY, latest qtr) | +1.4% | +5.8% |
| Net profit growth (YoY) | -23.2% | +14.6% |
| Gross margin | 69.1% | 39.5% |
| Operating margin | 20.6% | 12.9% |
| Net margin | 16.6% | 9.3% |
| Return on equity | – | 19.2% |
| Analyst target vs. price | +34.0% | +2.4% |
| Analyst buy share | 82% | 62% |
| RSI (14) | 45 | 72 |
| 30-day volatility | 38.7% | 36.0% |
| Max drawdown, 1 year | -60.4% | -32.5% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BSX is the largest of the group by market value.
- GEHC has returned the most over the past year.
- GEHC carries the lowest trailing P/E.
- GEHC is growing revenue fastest.
- BSX keeps the most profit per dollar of sales.
- GEHC has been the calmest stock over the last 30 days.